Novartis Recalls Theraflu Cold and Cough Powder Packets
Novartis is recalling Theraflu Daytime Severe Cold & Cough powder packets and NeoCitran products due to the potential presence of foreign substances.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves potential foreign substances without reported injuries or illnesses, fitting the criteria for a moderate severity score.
Plain-English summary
Novartis Consumer Health is recalling specific lots of Theraflu Daytime Severe Cold & Cough powder packets and NeoCitran Extra Strength Daytime Total 7 Symptom Relief powder packets. The recall involves 1,871,122 cartons distributed nationwide and in Mexico, Russia, Korea, Panama, China, and Canada.
The products are being recalled because they may contain foreign substances. The affected Theraflu products include Berry Infused with Menthol & Green Tea flavors, while the NeoCitran products include Invigorating Berry with Green Tea flavor. Specific lot numbers and expiration dates are listed in the recall notice.
Consumers should stop using the recalled products and check their lot numbers against the list provided by the FDA. Those with questions can contact Novartis Consumer Health for further information.
The recalled product
- Product
- Theraflu Daytime Severe Cold & Cough (acetaminophen 650 mg, dextromethorphan hydrobromide 20 mg, phenylephrine hydrochloride 10 mg) powder packets, Berry Infused with Menthol & Green Tea flavors, 6-count packets per carton, , Distributed by: Novartis Consumer Health, Inc., Parsip
- Manufacturer
- Novartis Consumer Health
- Category
- Drug — Cold and Flu
- Hazard
- Affected units
- 1,871,122
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: 10115840
- 10115888
- Exp 5/31/2013
- 10118946
- 10118948
- 10119864
- 10119867
- Exp 7/31/2013
- 10122271
- 10122297
- 10124374
- Exp 8/31/2013
- 10122300
- Exp 9/30/2013
- 10124493
- 10125910
- 10128097
- 10128099
- 10128101
- Exp 10/31/2013. NeoCitran Extra Strength Total 7 symptom relief: 10115129
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by Novartis Consumer Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Novartis Consumer Health
See all →- ModerateNovartis Recalls Benefiber Fiber Supplement Stick Packs Due to Consumer Complaints
FDA (Food) · 2014-03-05
- ModerateNovartis Recalls Theraflu Severe Cold & Cough Powder Packets for Foreign Substances
FDA (Drugs) · 2014-01-29
- HighNovartis Recalls Theraflu Powder Packets Due to Foreign Substance Presence
FDA (Drugs) · 2014-01-29
- ModerateNovartis Recalls NeoCitran Extra Strength Powder Packets Due to Foreign Substances
FDA (Drugs) · 2014-01-29
- ModerateNovartis Recalls Theraflu Exte Powder Packets Due to Foreign Substances
FDA (Drugs) · 2014-01-29
Same hazard · foreign substance
See all →- ModerateHeritage Pharmaceuticals Recalls Clindamycin Palmitate Hydrochloride Due to Foreign Particles
FDA (Drugs) · 2026-08-19
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01